Reports
L4 · 4.1June 5, 202612 min read

CLOCK/BMAL1 and the clock inside the ovary

Hormonal chronobiology·Chronobiology


Lua Labs Report — CLOCK/BMAL1 and the clock inside the ovary

Date: 2026-06-05 Researcher: Lua Labs Classification: Chronobiology Line: L4 — Hormonal chronobiology Sub-topic: 4.1 — CLOCK/BMAL1 genes and estradiol/progesterone rhythm: the clock inside the ovary

External sources

  1. Huang, L., Zhang, L., Shi, S., Zhou, X., Yuan, H., Song, X., Hu, Y., Pang, W., Yang, G., Gao, L., & Chu, G. (2023). "Mitochondrial function and E2 synthesis are impaired following alteration of CLOCK gene expression in porcine ovarian granulosa cells." Theriogenology, 202:51-60. DOI: https://doi.org/10.1016/j.theriogenology.2023.03.004
  2. Ecochard, R., Stanford, J. B., Fehring, R. J., Schneider, M., Najmabadi, S., & Gronfier, C. (2024). "Evidence that the woman's ovarian cycle is driven by an internal circamonthly timing system." Science Advances, 10(15):eadg9646. DOI: https://doi.org/10.1126/sciadv.adg9646
  3. Namie, T., Kotaka, T., Watanabe, K., Takasu, N. N., Nakamura, W., & Nakamura, T. J. (2024). "Menstrual variations of sleep-wake rhythms in healthy women." Sleep and Biological Rhythms, 23:5-12. DOI: https://doi.org/10.1007/s41105-024-00543-y
  4. Peters, B., Vahlhaus, J., & Pivovarova-Ramich, O. (2024). "Meal timing and its role in obesity and associated diseases." Frontiers in Endocrinology, 15:1359772. DOI: https://doi.org/10.3389/fendo.2024.1359772
  5. Ono, M., Ando, H., Daikoku, T., Fujiwara, T., Mieda, M., Mizumoto, Y., Iizuka, T., Kagami, K., Hosono, T., & Fujiwara, H. (2023). "The Circadian Clock, Nutritional Signals and Reproduction: A Close Relationship." International Journal of Molecular Sciences, 24(2):1545. DOI: https://doi.org/10.3390/ijms24021545
  6. Jiang, Y., Li, S., Xu, W., Ying, J., Qu, Y., Jiang, X., Zhang, A., Yue, Y., Zhou, R., Ruan, T., Li, J., & Mu, D. (2022). "Critical Roles of the Circadian Transcription Factor BMAL1 in Reproductive Endocrinology and Fertility." Frontiers in Endocrinology, 13:818272. DOI: https://doi.org/10.3389/fendo.2022.818272

Baseline knowledge (what I know before searching)

The molecular circadian clock is not a metaphor: it is a transcriptional circuit. CLOCK and BMAL1 form a heterodimer that binds to E-boxes in DNA and activates PER1/2, CRY1/2, REV-ERB and multiple metabolic output genes. PER/CRY return to the nucleus and inhibit CLOCK/BMAL1; REV-ERB and ROR regulate ARNTL/BMAL1. This loop lasts ~24 hours and exists in almost all tissues. The hypothalamic SCN synchronizes the organism with light, but the ovary, liver, intestine, adipose tissue and endometrium have peripheral clocks that also respond to food, temperature, inflammation and hormones.

In the female reproductive axis there are two superimposed temporal layers. The first is circadian: the SCN → AVPV/kisspeptin → GnRH/LH signal must arrive within a specific time window for the preovulatory follicle to respond. The second is infradian/circamonthly: folliculogenesis, estradiol peak, ovulation, luteinization and progesterone operate on a days-to-weeks scale. My starting point before searching papers: ovarian health does not depend only on the "quantity" of E2/P4, but on correct phase + correct time + correct tissue.

The ovary uses the clock to coordinate steroidogenesis with energy demand. To produce estradiol or progesterone, the granulosa/luteal cell must import cholesterol via StAR, convert it to pregnenolone by CYP11A1 in mitochondria, use HSD3B for progesterone and, in follicular granulosa, aromatize theca-derived androgens via CYP19A1 to generate E2. Each step requires NADPH, oxygen, mitochondrial integrity, FSH/LH signaling, insulin/IGF-1 sensitivity and nuclear coactivators. If CLOCK/BMAL1 loses amplitude, the cell does not merely "desynchronize"; it loses the ability to anticipate the energetic cost of ovulating.

This immediately connects with L1-L3. L1 showed that the microbiome and vagus modulate CRH, LPS, SCFAs and hormonal recirculation. L2 showed that cortisol is not noise: it has a diurnal curve, diurnal cortisol A/B phenotypes and competes/cooperates with progesterone depending on phase. L3 concluded that TSH/T3, insulin and SHBG form a reverberating triangle with PCOS. L4 does not add a new topic; it adds the temporal axis that decides when those mechanisms are expressed.

Findings from recent papers

Huang et al. 2023 grounds the mechanism in granulosa cells: altering CLOCK impairs mitochondrial function and E2 synthesis, with decreased steroidogenic genes such as CYP19A1, CYP11A1 and StAR. It is a porcine model, not a human one, but the molecular point is strong: the clock does not merely accompany steroidogenesis, it enables it metabolically. Jiang et al. 2022 consolidates that BMAL1 knockdown in steroidogenic cells reduces progesterone and estradiol, and that the genes StAR, Cyp11a1, Cyp19a1, Lhcgr and Hsd3b2 appear as clock-dependent outputs.

Ono et al. 2023 allows integrating the central and peripheral axes: the SCN controls kisspeptin/LH, but LH and FSH also synchronize the ovarian clock. In the ovary, Per1/Per2 oscillate in follicles, granulosa, theca and corpus luteum; LH promotes Per1 and Bmal1. The relevant point is not that "sleep affects fertility", but that gonadotropins and the clock synchronize each other. If sleep, food or cortisol shift the peripheral clock while LH arrives on time in the central axis, a central-peripheral misalignment appears: the correct signal in a tissue that is no longer prepared.

Ecochard et al. 2024 analyzed 26,912 cycles from 2,303 European women and 4,786 cycles from 721 North American women, and found evidence of an internal circamonthly timer and weak but significant relationships with the lunar cycle. One need not accept a strong lunar explanation for the data to be useful: what matters is that the cycles show properties of an oscillatory system, with autocorrelation and relative coordination. Namie et al. 2024 took this to measurable behavior: in 10 healthy women with actigraphic recording, the sleep midpoint and the robustness of the rhythm varied by menstrual phase; robustness was higher in the follicular than in the menstrual/luteal phase, and greater social jetlag was associated with longer cycles. The n is small, but it illustrates the kind of behavioral signal that correlates with cycle phase.

Peters et al. 2024 and the chrononutrition literature complete the bridge from L3.4. Food is a powerful peripheral zeitgeber: it can synchronize liver, intestine, muscle and pancreas, even when the SCN remains anchored to light. Eating late or at night decouples peripheral clocks, worsens glycemic/insulinemic response and shifts signals such as leptin, insulin, glucagon, adiponectin and cortisol. In a woman with high metabolic-reproductive phenotype, this is not a "habit"; it is a modulator of CYP17A1/CYP19A1, SHBG, DIO2 and granulosa sensitivity to LH/FSH.

Complete molecular/endocrine mechanism

The ovarian clock operates as a temporal gate for steroidogenesis:

AM light → SCN → AVPV kisspeptin → GnRH → LH/FSH → follicle
                                  ↓
                       synchronizes ovarian CLOCK/BMAL1

CLOCK + BMAL1 → E-box → StAR/CYP11A1/HSD3B/CYP19A1/LHCGR/PTGS2
      ↓
window of mitochondrial competence + response to LH/FSH
      ↓
high follicular E2 on time → positive feedback → LH surge → ovulation
      ↓
luteinization → circadian/luteal P4 → endometrium + CNS + GR

The steroidogenic chain:

Cholesterol → StAR → mitochondria → CYP11A1 → pregnenolone
                                      ↓
                             HSD3B → progesterone → PR/GR/indirect GABA-A
                                      ↓
Theca: progesterone → CYP17A1 → androstenedione/testosterone
                                      ↓
Granulosa: CYP19A1 aromatase + FSH → estradiol → ERα/ERβ → HPO feedback
                                      ↓
                  Prior modulators: metabolic-reproductive phenotype/insulin, thyroid-symptom phenotype/T3, diurnal cortisol phenotype/cortisol

The central mechanistic hypothesis of L4.1: CLOCK/BMAL1 defines the window of ovarian sensitivity. LH may be present, FSH may be present and the substrate may exist, but if the peripheral tissue is phase-shifted by irregular sleep, late eating, nocturnal cortisol or inflammation, the cell may respond with lower StAR/CYP11A1/CYP19A1 or with incorrect timing. The result would not necessarily be "low" E2/P4 in an isolated measurement; it would be low temporal hormonal amplitude, visible as more variable cycles, a less stable luteal phase, worse luteal sleep and phase-specific postprandial symptoms.

Intersection with L3.4:

Late dinner / erratic eating window → phase-shifted hepatic/pancreatic clock
      ↓
nocturnal insulin + altered leptin + lower hepatic SHBG
      ↓
↑ free androgens + ↑ theca CYP17A1 signal + ↓ granulosa sensitivity
      ↓
amplified PCOS/metabolic-reproductive phenotype
      ↓
The same pattern shifts ovarian CLOCK/BMAL1 and reduces E2/P4 efficiency

Intersection with L2:

Fragmented sleep / social jetlag → evening cortisol or altered CAR
      ↓
diurnal cortisol phenotype A: high peak + sleep-onset insomnia → DIO2↓ + dominant GR
diurnal cortisol phenotype B: flat amplitude + fatigue → low inflammation + weak clock signal
      ↓
SCN-HPA-ovary phase shift → lower robustness of LH pulse / luteal response

Intersection with L1:

Irregular eating → irregular oscillating microbiota + low nocturnal motility
      ↓
out-of-phase SCFAs + late postprandial LPS
      ↓
afferent vagus / NTS / PVN-CRH + granulosa inflammation
      ↓
misalignment of the distributed metabolic-neural sub-organ

Cross-synthesis with previous findings

  • L1 — Microbiome + vagus: L4 converts biological quality into temporal quality. A pro-microbial diet can fail if it arrives at times that decouple the intestinal and ovarian clocks. The new question is not only what she ate, but whether the microbial stimulus occurred in a compatible circadian phase.
  • L2 — Cortisol and HPA load: L4 explains why circadian calibration is not an accessory component. Diurnal cortisol is both a synchronizer and a disruptor. In hyperreactive phenotypes, the probable problem is excess signal at night or high CAR; in low-amplitude phenotypes, loss of signal. Both can be seen as phenotypes of low clock-HPA-ovary coherence.
  • L2.3 — GR as phase sensor: GR does not only change by menstrual phase; it also changes by time of day. P4 and cortisol can cooperate in physiological windows and antagonize in incorrect windows. The ovarian clock determines whether the cell interprets cortisol as an ovulatory co-signal or as allostatic load.
  • L3 — Thyroid/metabolism/reproduction: TSH has a circadian rhythm, DIO2 is cortisol-sensitive, insulin is circadian and SHBG is hepatic. L4 shows that the thyroid-reproductive axis is incomplete without timing. The same TSH 2.8 or the same carbohydrate-rich dinner does not have the same effect if it occurs with a robust vs phase-shifted clock.

Lua Labs Hypotheses

Hypothesis 23: Ovarian circadian coherence

Statement: In women with an active cycle or early perimenopause, low coherence between sleep timing, meal timing and cycle phase predicts greater inter-cycle variability, a less stable luteal phase and greater functional metabolic-androgenic load, independent of age and total food volume.

Proposed mechanism: The hypothesis models three synchronizers: light/sleep, food and hormonal phase. When sleep midpoint shifts >90 min between days, the first meal varies >2 h, the last meal occurs close to sleep and the luteal phase concentrates fragmented sleep/low mood, an SCN-HPA-liver-pancreas-ovary misalignment is created. In the ovary, that misalignment reduces CLOCK/BMAL1 amplitude, lowers mitochondrial efficiency of StAR/CYP11A1/CYP19A1 and shifts the response window to LH/FSH. In the liver, it lowers SHBG; in the pancreas, it worsens insulin; in the HPA, it alters cortisol. Result: more free androgen, more luteal symptoms, worse sleep in luteal and less regular cycles.

Confidence level: Medium — high for the existence of reproductive clocks and metabolic meal timing; low-medium for direct ovarian specificity in humans.

How to validate:

  • With a formal study: observational, n=120, 3 cycles, actigraphy/sleep diary + urinary LH or basal body temperature, with an n=40 subgroup adding serial salivary or serum E2/P4 over 2 cycles. Goal: correlation of circadian coherence with luteal P4 amplitude and ovulation timing; target AUC ≥0.70 for an altered luteal phase.

Limitations: The weakest link is inferring the ovarian clock from behavior. Sleep/food may be markers of stress, work, motherhood or chronotype, not a direct cause. Correction is required for timezone, chronotype, night shifts, hormonal contraceptives and adherence.

Hypothesis 24: Luteal window of circadian vulnerability

Statement: The mid-late luteal phase is the window in which circadian misalignment produces the greatest symptomatic cost, because P4 increases body temperature, modulates GABA-A and competes/co-signals with cortisol at GR while the corpus luteum depends on CLOCK/BMAL1 output to maintain steroidogenesis.

Proposed mechanism: In luteal, P4 and metabolites such as allopregnanolone should stabilize sleep and GABA-A tone, but they also raise basal temperature and can fragment sleep in sensitive women. If there is late dinner + evening cortisol + variable sleep midpoint, the nocturnal GR signal becomes dominant precisely when PR should support the endometrium and CNS. This inherits L2.3: "functional P4 withdrawal" can occur due to temporal desynchrony even if absolute P4 is not critically low. It inherits L3.2: if tissue T3 is low, the corpus luteum has lower compensatory capacity.

Confidence level: Medium — the sleep-by-phase pattern exists, but the specific P4-GR-CLOCK interaction is a Lua Labs synthesis pending validation.

How to validate:

  • With a formal study: natural observational crossover, n=80, two cycles, actigraphy/sleep diary + dietary timing diary + LH ovulation. Primary outcome: phase × meal timing × sleep midpoint interaction on luteal symptoms and basal temperature.

Limitations: Without confirming ovulation, the estimated "luteal" phase may be false in PCOS/anovulation. In perimenopause, frequent anovulatory cycles may dilute the signal. Hormonal contraceptives alter endogenous P4/E2 and must be separated.

Hypothesis 25: Circadian misalignment and the metabolic-reproductive triangle

Statement: In women with PCOS or insulin resistance, variability in first-meal timing and late energy intake amplifies the metabolic-androgenic branch more than isolated weekly dietary composition, because the hepatic-pancreatic-thecal peripheral clock modulates SHBG, insulin and CYP17A1.

Proposed mechanism: Late eating generates a greater glycemic/insulinemic response because of lower circadian sensitivity. In the liver, insulin lowers SHBG; in theca, insulin/IGF-1 amplify LH and CYP17A1; in granulosa, IR reduces efficient aromatization to E2. If ovarian CLOCK/BMAL1 is phase-shifted, the follicle receives a stronger androgenic signal in a window of lower aromatase capacity. This predicts mandibular acne, postprandial cravings, reactive hypoglycemia and long/irregular cycles.

Confidence level: Medium-High for circadian metabolism; medium for the human theca-granulosa link.

How to validate:

  • With a formal study: n=100 women with PCOS or insulin resistance, 12 weeks, dietary timing diary + optional CGM + SHBG/free testosterone/HOMA-IR baseline and week 12.

Limitations: Meal timing cannot be fully separated from chronotype, night work or social context, which covary with one another. Recorded timing also does not always equal the actual time of intake, so the moment of consumption should be captured as directly as possible.

Candidate formulation (if applicable)

Compounds: No pharmacological formulation is proposed in this session. The useful scientific output is a circadian coherence/validation framework for observational studies, not an individual-use recommendation or a supplement.

Target population: Women with an active cycle and luteal symptoms; adolescents and young women with possible PCOS or metabolic-reproductive phenotype; and women in early perimenopause with fragmented sleep and cycle variability. Postmenopausal circadian amplitude remains a future extension, not an ovulatory clock.

Complementary mechanisms: sleep/light as the SCN-HPA synchronizer; food as the hepatic-pancreatic-intestinal synchronizer; cycle phase as the ovarian synchronizer; AM/PM symptoms as the output readout.

Requires validation: observational study + sub-study with ovulation and luteal P4 before any indirect ovarian-clock marker claim.

Individual variability

The same circadian misalignment will not have the same effect in everyone. Clock-gene variants (CLOCK, ARNTL/BMAL1, PER3, CRY1/2, NPAS2) can change chronotype, rhythm amplitude and the response to light and food. The PER3 VNTR is associated with vulnerability to sleep deprivation; CRY1 can delay circadian phase; and CLOCK variants have been associated with meal timing and metabolism. This explains why some women keep symptoms despite good dietary composition when they hold a rigid night chronotype.

Inherited endocrine-metabolic genetics matter: DIO2 Thr92Ala (L3.1-L3.4) may make the same irregular sleep produce greater fatigue/thyroid-symptom phenotype through low tissue T3; TCF7L2/INSR/IRS1 may amplify the cost of late eating; CYP19A1/CYP17A1 may change the E2-androgen direction; FKBP5/NR3C1 may define how much nocturnal cortisol deactivates P4/PR signaling. It is not "sleep discipline"; it is differential molecular sensitivity.

The environment also stratifies. Night shifts, motherhood, caregiving for dependents, job insecurity, travel, exposure to artificial light, late LATAM social dinners and evening caffeine are not minor variables. In urban Mexican women, chronodisruption may be culturally normalized: late dinner + screen + early waking. L4 must distinguish social pattern from biological failure without blaming the user.


Notice. Lua Labs is a scientific research laboratory. Reports are literature syntheses, not medical advice. Any clinical decision should be made with a health professional.